Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
24.4%
% of GDOC's 43 holdings also in FBT
33.3%
% of FBT's 31 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 3.4% | 3.7% | 3.4% |
|
BIOMARIN PHARMACEUTICAL INC | 3.0% | 3.2% | 3.0% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% | 3.0% | 3.0% |
|
AMGEN INC | 4.6% | 2.8% | 2.8% |
|
BIOGEN IDEC INC | 2.8% | 2.7% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to FBT
|
ELI LILLY & CO | 10.4% |
 |
ASTRAZENECA PLC | 6.2% |
|
BOSTON SCIENTIFIC CORP | 5.9% |
 |
NOVO NORDISK A/S-B | 5.8% |
|
INTUITIVE SURGICAL INC | 5.0% |
|
ABBVIE INC | 4.7% |
|
DANAHER CORP | 3.8% |
|
INSULET CORP | 3.4% |
|
HUMANA INC | 3.4% |
|
COOPER COS INC/THE | 3.3% |
GDOC Underweight Relative to FBT
|
EXELIXIS INC | -4.5% |
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
REPLIGEN CORP | -3.8% |
|
NATERA INC | -3.8% |
|
GILEAD SCIENCES INC | -3.6% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
WATERS CORP | -3.6% |
 |
ALKERMES PLC | -3.6% |
|
INCYTE CORP | -3.5% |